Key Insights

Highlights

Success Rate

83% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 49/100

Termination Rate

8.3%

1 terminated out of 12 trials

Success Rate

83.3%

-3.2% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed with results

Key Signals

2 with results83% success

Data Visualizations

Phase Distribution

8Total
Not Applicable (8)

Trial Status

Completed5
Recruiting3
Enrolling By Invitation1
Withdrawn1
Not Yet Recruiting1
Terminated1

Trial Success Rate

83.3%

Benchmark: 86.5%

Based on 5 completed trials

Clinical Trials (12)

Research Network

Activity Timeline